Antibody Drug Conjugate (ADC) Drug Market Report

Global and Region Antibody Drug Conjugate (ADC) Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：199
  • REPORT CODE：GMM1003348
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Antibody Drug Conjugate (ADC) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Antibody Drug Conjugate (ADC) Drugmarket, defines the market attractiveness level of Antibody Drug Conjugate (ADC) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Antibody Drug Conjugate (ADC) Drug industry, describes the types of Antibody Drug Conjugate (ADC) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibody Drug Conjugate (ADC) Drug market and the development prospects and opportunities of Antibody Drug Conjugate (ADC) Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibody Drug Conjugate (ADC) Drug market in Chapter 13.

    By Player:

    • Bayer HealthCare

    • Genentech

    • Oxford Bio Therapeutics

    • Genmab

    • Celldex Therapeutics

    • Novartis

    • Pfizer

    • Progenics Pharmaceuticals

    • Roche Holding AG

    • AbbVie Inc

    • Agensys

    • Amgen

    • Seattle Genetics

    • Eli Lilly

    • Astellas Pharma/Agensys

    • Sanofi

    • Millennium Pharmaceuticals

    • Immunomedics

    • ImmunoGen

    • Mersana Therapeutics

    • Synthon

    • Heidelberg Pharma

    • Concortis Bio therapeutics

    By Type:

    • by Technology

    • Mmunomedics Technology

    • Immunogen Technology

    • Roche Holding AG Technology

    • Others

    • by Product Type

    • Kadcyla

    • Adcertis

    By End-User:

    • Biotechnology Companies

    • Specialized Cancer Centers

    • Biopharmaceutical Companies

    • Academic Research Institutes

    • Hospitals

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Antibody Drug Conjugate (ADC) Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Antibody Drug Conjugate (ADC) Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Antibody Drug Conjugate (ADC) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Antibody Drug Conjugate (ADC) Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Antibody Drug Conjugate (ADC) Drug Market Analysis and Outlook to 2022

    • 7.1 Global Antibody Drug Conjugate (ADC) Drug Consumption (2017-2022)

    • 7.2 United States Antibody Drug Conjugate (ADC) Drug Consumption (2017-2022)

    • 7.3 Europe Antibody Drug Conjugate (ADC) Drug Consumption (2017-2022)

    • 7.4 China Antibody Drug Conjugate (ADC) Drug Consumption (2017-2022)

    • 7.5 Japan Antibody Drug Conjugate (ADC) Drug Consumption (2017-2022)

    • 7.6 India Antibody Drug Conjugate (ADC) Drug Consumption (2017-2022)

    • 7.7 South Korea Antibody Drug Conjugate (ADC) Drug Consumption (2017-2022)

    8 Region and Country-wise Antibody Drug Conjugate (ADC) Drug Market Analysis and Outlook to 2028

    • 8.1 Global Antibody Drug Conjugate (ADC) Drug Consumption Forecast (2022-2028)

    • 8.2 United States Antibody Drug Conjugate (ADC) Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Antibody Drug Conjugate (ADC) Drug Consumption Forecast (2022-2028)

    • 8.4 China Antibody Drug Conjugate (ADC) Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Antibody Drug Conjugate (ADC) Drug Consumption Forecast (2022-2028)

    • 8.6 India Antibody Drug Conjugate (ADC) Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Antibody Drug Conjugate (ADC) Drug Consumption Forecast (2022-2028)

    9 Global Antibody Drug Conjugate (ADC) Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global by Technology Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Mmunomedics Technology Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunogen Technology Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Roche Holding AG Technology Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global by Product Type Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Kadcyla Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Adcertis Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Specialized Cancer Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Academic Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Antibody Drug Conjugate (ADC) Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global by Technology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Mmunomedics Technology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Immunogen Technology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Roche Holding AG Technology Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global by Product Type Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Kadcyla Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Adcertis Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Specialized Cancer Centers Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Academic Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Antibody Drug Conjugate (ADC) Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Antibody Drug Conjugate (ADC) Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Antibody Drug Conjugate (ADC) Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Antibody Drug Conjugate (ADC) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Antibody Drug Conjugate (ADC) Drug Market Competitive Analysis

    • 14.1 Bayer HealthCare

      • 14.1.1 Bayer HealthCare Company Details

      • 14.1.2 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.2 Genentech

      • 14.2.1 Genentech Company Details

      • 14.2.2 Genentech Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Genentech Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.3 Oxford Bio Therapeutics

      • 14.3.1 Oxford Bio Therapeutics Company Details

      • 14.3.2 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.4 Genmab

      • 14.4.1 Genmab Company Details

      • 14.4.2 Genmab Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Genmab Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.5 Celldex Therapeutics

      • 14.5.1 Celldex Therapeutics Company Details

      • 14.5.2 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.6 Novartis

      • 14.6.1 Novartis Company Details

      • 14.6.2 Novartis Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novartis Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.7 Pfizer

      • 14.7.1 Pfizer Company Details

      • 14.7.2 Pfizer Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Pfizer Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.8 Progenics Pharmaceuticals

      • 14.8.1 Progenics Pharmaceuticals Company Details

      • 14.8.2 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.9 Roche Holding AG

      • 14.9.1 Roche Holding AG Company Details

      • 14.9.2 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.10 AbbVie Inc

      • 14.10.1 AbbVie Inc Company Details

      • 14.10.2 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.11 Agensys

      • 14.11.1 Agensys Company Details

      • 14.11.2 Agensys Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Agensys Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.12 Amgen

      • 14.12.1 Amgen Company Details

      • 14.12.2 Amgen Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Amgen Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.13 Seattle Genetics

      • 14.13.1 Seattle Genetics Company Details

      • 14.13.2 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.14 Eli Lilly

      • 14.14.1 Eli Lilly Company Details

      • 14.14.2 Eli Lilly Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.15 Astellas Pharma/Agensys

      • 14.15.1 Astellas Pharma/Agensys Company Details

      • 14.15.2 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.16 Sanofi

      • 14.16.1 Sanofi Company Details

      • 14.16.2 Sanofi Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Sanofi Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.17 Millennium Pharmaceuticals

      • 14.17.1 Millennium Pharmaceuticals Company Details

      • 14.17.2 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.18 Immunomedics

      • 14.18.1 Immunomedics Company Details

      • 14.18.2 Immunomedics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.19 ImmunoGen

      • 14.19.1 ImmunoGen Company Details

      • 14.19.2 ImmunoGen Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.20 Mersana Therapeutics

      • 14.20.1 Mersana Therapeutics Company Details

      • 14.20.2 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.21 Synthon

      • 14.21.1 Synthon Company Details

      • 14.21.2 Synthon Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Synthon Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.22 Heidelberg Pharma

      • 14.22.1 Heidelberg Pharma Company Details

      • 14.22.2 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product and Service

    • 14.23 Concortis Bio therapeutics

      • 14.23.1 Concortis Bio therapeutics Company Details

      • 14.23.2 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Antibody Drug Conjugate (ADC) Drug

    • Figure Antibody Drug Conjugate (ADC) Drug Picture

    • Table Global Antibody Drug Conjugate (ADC) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Antibody Drug Conjugate (ADC) Drug Consumption by Country (2017-2022)

    • Figure United States Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate (2017-2022)

    • Figure China Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate (2017-2022)

    • Figure India Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antibody Drug Conjugate (ADC) Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Antibody Drug Conjugate (ADC) Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antibody Drug Conjugate (ADC) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global by Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Mmunomedics Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Immunogen Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Roche Holding AG Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global by Product Type Consumption and Growth Rate (2017-2022)

    • Figure Global Kadcyla Consumption and Growth Rate (2017-2022)

    • Figure Global Adcertis Consumption and Growth Rate (2017-2022)

    • Figure Global Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Specialized Cancer Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Academic Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global by Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mmunomedics Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunogen Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Roche Holding AG Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global by Product Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kadcyla Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adcertis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialized Cancer Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Academic Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Antibody Drug Conjugate (ADC) Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Bayer HealthCare (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Oxford Bio Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Genmab (Foundation Year, Company Profile and etc.)

    • Table Genmab Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genmab Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Celldex Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Progenics Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Roche Holding AG (Foundation Year, Company Profile and etc.)

    • Table Roche Holding AG Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Agensys (Foundation Year, Company Profile and etc.)

    • Table Agensys Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agensys Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Seattle Genetics (Foundation Year, Company Profile and etc.)

    • Table Seattle Genetics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Astellas Pharma/Agensys (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Millennium Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Immunomedics (Foundation Year, Company Profile and etc.)

    • Table Immunomedics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomedics Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table ImmunoGen (Foundation Year, Company Profile and etc.)

    • Table ImmunoGen Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table ImmunoGen Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Mersana Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Synthon (Foundation Year, Company Profile and etc.)

    • Table Synthon Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Synthon Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Heidelberg Pharma (Foundation Year, Company Profile and etc.)

    • Table Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product and Service

    • Table Concortis Bio therapeutics (Foundation Year, Company Profile and etc.)

    • Table Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US